Implantable Drug Delivery Devices Market Intelligence Report Offers Growth Prospects 2020-2025 | Global Key Vendors - Bayer, Allergan, Medtronic, Nucletron, Merck, Boston Scientific, Abbott

Global Implantable Drug Delivery Devices Market Synopsis:

The report covers a forecast and an analysis of the Implantable Drug Delivery Devices Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Implantable Drug Delivery Devices Market along with the impact they have on the demand over the forecast period.

Most important key factors driving the growth of the Global Implantable Drug Delivery Devices Market are rapid growth in the geriatric population, increase in the number of cancer cases, a growing number of cardiology, ophthalmology abnormalities and the rise in technological advancements. Furthermore, the risk of infection, risk of overdose/under-dose due to technical difficulty of the devices, high cost will likely to restrain the growth of the market. Merger and acquisition activities among leading service providers will enlighten the opportunities for the same market for the growth over the forecast period.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/273375 .

On the basis of geographic analysis, North America held the largest share in the market in 2016 as a consequence of extensive new development activities undertaken by leading players. Growing disease burden across this region has also resulted in high clinical urgency to adopt these devices. APAC is anticipated to exhibit an exponential CAGR during the forecast period, attributed to steadily growing healthcare spending as well as awareness levels with respect to benefits of Implantable Drug Delivery Devices.

This report contains a complete product overview and its scope in the market to define the key terms and provide the clients a holistic idea of the market and its tendency. It comprehensively evaluates the Global Implantable Drug Delivery Devices Market with different perspectives for the purpose of providing a detailed, informative, and accurate analysis of regional growth, competition, market segmentation, and other important aspects.

Global Key Players:

1 Allergan

2 Bayer HealthCare

3 Medtronic

4 Nucletron

5 Merck

6 PSivida Corp.

7 Boston Scientific Corporation

8 Abbott Laboratories

9 Bausch and Lomb and More……………

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “Global Implantable Drug Delivery Devices Market Report 2020” @ https://www.businessindustryreports.com/buy-now/273375/single .

Product Type Segmentation

1 Biodegradable

2 Non-biodegradable

Industry Segmentation

1 Contraception

2 Ophthalmology

3 Cardiovascular

4 Diabetes

5 Oncology

Top Medical Industry News:

Bayer (June 15, 2020) - Bayer extends clinical development program for finerenone with Phase III study in patients with heart failure and preserved ejection fraction - Bayer announced today the initiation of the FINEARTS-HF study, a multicenter, randomized, double-blind, placebo-controlled Phase III study to evaluate the efficacy and safety of finerenone on morbidity and mortality in patients suffering from symptomatic heart failure (New York Heart Association class II-IV) with a left ventricular ejection fraction of more than or equal to 40%. The primary objective of the study is to demonstrate superiority of finerenone over placebo in reducing the rate of the composite endpoint of cardiovascular death and total (first and recurrent) heart failure (HF) events (defined as hospitalizations for HF or urgent HF visits).

“No therapy is currently approved for patients with heart failure and preserved ejection fraction. These patients have a substantial risk for cardiovascular events, which represents an enormous unmet need in cardiovascular disease,” said Scott D. Solomon, MD, The Edward D. Frohlich Distinguished Chair, Professor of Medicine at Harvard Medical School, Director of Non-invasive Cardiology and Senior Physician at Brigham and Women’s Hospital and Chair of the study’s Executive Committee. “The FINEARTS-HF study will assess whether finerenone leads to a reduction in the risk of cardiovascular death and other heart failure events in these underserved patients.”

“Blockade of the mineralocorticoid receptor system has been shown to be of benefit in the treatment of heart failure. With the novel compound finerenone, Bayer is pursuing a new research approach in another heart failure patient population where a targeted therapy to reduce mortality and morbidity is still lacking,” said Dr. Joerg Moeller, Member of the Executive Committee of Bayer AG's Pharmaceutical Division and Head of Research and Development. “We are excited about finerenone being the first non-steroidal mineralocorticoid receptor antagonist that is being developed in heart failure with preserved ejection fraction.”

The planned Phase III FINEARTS-HF study will investigate finerenone compared to placebo in more than 5,500 symptomatic heart failure patients with a left ventricular ejection fraction of ≥40%. Patients will be randomized to receive either finerenone once daily (titrated up to 40 mg) or placebo. The study will be conducted in more than 34 countries including sites in Europe, Japan, China and the U.S.

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/273375 .

Major Points in Table of Contents:

Global Implantable Drug Delivery Devices Market Report 2020

1 Implantable Drug Delivery Devices Product Definition

2 Global Implantable Drug Delivery Devices Market Manufacturer Share and Market Overview

2.1 Global Manufacturer Implantable Drug Delivery Devices Shipments

2.2 Global Manufacturer Implantable Drug Delivery Devices Business Revenue

2.3 Global Implantable Drug Delivery Devices Market Overview

2.4 COVID-19 Impact on Implantable Drug Delivery Devices Industry

3 Manufacturer Implantable Drug Delivery Devices Business Introduction

3.1 Allergan Inc. Implantable Drug Delivery Devices Business Introduction

3.2 Bayer HealthCare Implantable Drug Delivery Devices Business Introduction

3.3 Medtronic Inc. Implantable Drug Delivery Devices Business Introduction

3.4 Nucletron Implantable Drug Delivery Devices Business Introduction

3.5 Merck Implantable Drug Delivery Devices Business Introduction

3.6 PSivida Corp. Implantable Drug Delivery Devices Business Introduction

About us

BusinessindustryReports.com is a digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic, and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.